Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
Mark Althoff Scribble in Hematopoietic Stem Cell Activity National Institutes of Health F31 HL132468 4/1/2016 - 3/31/2019 $36,036
Laura Barreyro, PHD Environmental Carcinogenesis and Mutagenesis Training Grant National Institutes of Health (University of Cincinnati) T32 ES007250 9/30/2015 - 9/29/2018 $48,192
Elisa Boscolo, PHD Venous Malformations (VM): A Murine Model to Identify Therapies to Target Aberrant Venous Development National Institutes of Health R01 HL117952 8/7/2014 - 4/30/2018 $351,000
Jose Cancelas-Perez Validation of a Rationally Designed Guanine Nucleotide Exchange Factor Inhibitor in Lymphoblastic Leukemia Wm Lawrence & Blanche Hughes Foundation (USC Parker Institute for) Cancelas, Jose, WLBH 1/1/2014 - 12/31/2016 $70,000
Jose Cancelas-Perez;Carolyn M Lutzko G-CSF in Human Severe Congenital Neutropenia National Institutes of Health R01 GM110628 7/1/2015 - 6/30/2019 $308,100
Jose Cancelas-Perez Development of a Method to Store Refrigerated Platelets for Human Transfusion National Institutes of Health (Cleveland Clin Lerner Col of Med of CWRU) U54 HL119810 8/1/2015 - 7/31/2016 $195,000
Kyung Hee Chang Angiotensin in Stem Cell Recruitment and Mobilization National Blood Foundation Change, Kyung, NBF 7/1/2014 - 6/30/2016 $37,500
Chris Richard Evelyn, PHD Environmental Carcinogenesis and Mutagenesis Training Grant National Institutes of Health (University of Cincinnati) T32 ES007250 11/19/2015 - 11/18/2016 $52,116
Jing Fang Mechanisms linking p62/SQSTM1 to the Evolution of Myelodyplastic Syndrome Aplastic Anemia & MDS International Fdn Fang, Jing, AAMDS 7/1/2015 - 4/17/2016 $30,000
Marie-Dominique Filippi, PHD Hypoxia and Potassium Channel Activity in T Lymphocytes National Institutes of Health (University of Cincinnati) R01 CA095286 7/1/2015 - 6/30/2018 $9,185
Marie-Dominique Filippi, PHD Molecular Regulation of Neutrophil Transcellular Migration National Institutes of Health R01 GM112792 7/1/2015 - 6/30/2019 $308,100
Marie-Dominique Filippi, PHD
Punam Malik, MD		 Regulation of Hematopoietic Stem Cell Self-renewal by GTPase Activating Protein Signaling National Institutes of Health R01 DK102890 7/1/2015 - 6/30/2020 $426,291
Jonathan Fletcher Cytokine Signaling in Neurofibroma Development National Institutes of Health F30 NS096796 3/1/2016 - 2/28/2018 $40,176
Matthew Flick, PHD Novel Anti-fibrotic Mechanisms in Chemical-induced Liver Injury National Institutes of Health (Michigan State University) R01 ES017537 8/1/2015 - 6/30/2020 $35,058
Hartmut Geiger, PHD Novel t-MDS Predisposing Genes and Pathways Edward P. Evans Foundation BSR2015 9/1/2015 - 8/31/2016 $200,000
Hartmut Geiger, PHD Molecular Mechanisms and Therapies for Radiation-Induced Myelodysplastic Syndrome (MDS) University of Kentucky UKRF-Hartmut 4/1/2012 - 9/30/2015 $100,000
FuKun Guo, PHD Novel Signaling Function of Cdc42 GTPase In Vivo National Institutes of Health R01 GM108661 5/1/2014 - 2/28/2018 $273,000
FuKun Guo, PHD Novel Therapeutics of Targeting mTOR Pathway in T-cell Leukemia National Institutes of Health R21 CA198358 7/10/2015 - 6/30/2017 $373,230
Cindy LF Hochstetler Unraveling the Mystery of How Bad Homes and Bad Cells can lead to Leukemia Development and Relapse Cancer Free Kids wong, cindy, cfk 7/1/2015 - 6/30/2016 $15,000
Kakajan Komurov, PHD Modeling and Targeting the Hexosamine Pathway in Drug Resistance Susan G Komen for the Cure CCR13263034 8/1/2013 - 7/31/2016 $150,000
Kakajan Komurov, PHD Exploiting Proteotoxic Stress in Therapy-refractory HER2+ Breast Cancers National Institutes of Health R01 CA193549 5/1/2015 - 4/30/2020 $356,850
Qing Richard Lu, PHD Histone Deacetylase Control of CNS Myelination and Remyelination National Multiple Sclerosis Society Lu, Qing, NMSS 4/1/2015 - 3/31/2018 $249,975
Qing Richard Lu, PHD A Novel Therapeutic Approach for Medulloblastoma Treatment University of Cincinnati M16 12/1/2015 - 11/30/2016 $50,000
Qing Richard Lu, PHD The Establishment of Schwann Cell Polarity and the Initiation of Myelination National Institutes of Health (The Univ of California, San Francisco) R01 NS062796 5/1/2014 - 4/30/2019 $122,850
Qing Richard Lu, PHD Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination National Institutes of Health R01 NS072427 9/20/2015 - 8/31/2020 $466,702
Qing Richard Lu, PHD Chromatin Remodeling Control of CNS Myelination and Remyelination National Institutes of Health R01 NS075243 10/1/2013 - 3/31/2017 $341,250
Qing Richard Lu, PHD A Novel Model of Medulloblastoma to Define Cancer Pathways and Molecular Targets National Institutes of Health R01 NS078092 10/1/2013 - 3/31/2017 $341,250
Qing Richard Lu, PHD Chd7 Chromatin Remodeller Function in Myelination and Remyelination National Multiple Sclerosis Society (Inserm Délégation Régionale Paris 6) RG150102851 10/1/2015 - 9/30/2018 $89,360
Qing Richard Lu, PHD Long Non-coding RNA Control of CNS Myelination and Remyelination National Multiple Sclerosis Society RG150705671 4/1/2016 - 3/31/2019 $232,880
Punam Malik, MD Gene Therapy for Sickle Cell Anemia Doris Duke Charitable Foundation 2013122 9/1/2013 - 8/31/2016 $162,000
Punam Malik, MD PLGF-HIF1a-miR Axis in Sickle Pulmonary Hypertension National Institutes of Health (University of Southern California) R01 HL111372 1/1/2012 - 12/31/2016 $239,445
Punam Malik, MD
Matthew Flick, PHD		 Hemostatic Factors and Sickle Cell Disease National Institutes of Health R01 HL112603 12/1/2015 - 11/30/2016 $382,500
Punam Malik, MD Cincinnati Cell Characterization Core National Institutes of Health (University of Maryland (College Park)) U01 HL099997 9/1/2010 - 4/30/2017 $253,614
James Mulloy, PHD Conferring In Vivo Metabolic Resistance to a Highly Selective Anti-AML Agent National Institutes of Health (University of Cincinnati) R21 CA185370 5/1/2014 - 2/28/2016 $38,250
James Mulloy, PHD A New Hydrogen Peroxide-Activated Agent that Selectively Targets AML Cancer Cells University of Cincinnati TR000077 7/1/2015 - 6/30/2016 $40,291
Nicolas Nassar, PHD Novel Rationally Designed Ras Inhibitors for B-ALL Multi-target Therapy The Leukemia and Lymphoma Society 607614 10/1/2013 - 9/30/2016 $200,000
Nancy Ratner, PHD An Innovative NF1 Drug Discovery Pipeline for Preclinical Development of Novel Drugs Quickly, Safely and Effectively The Children's Tumor Foundation (The Children's Tumor Foundation) CTF 10/15/2015 - 6/30/2018 $75,891
Nancy Ratner, PHD Mechanisms of Resistance to MEK Inhibition in Neurofibroma The Children's Tumor Foundation 2015B05003 11/18/2015 - 11/18/2016 $85,000
Nancy Ratner, PHD Neurofibroma Preclinical Therapeutics The Children's Tumor Foundation CTF 7/15/2013 - 7/14/2016 $351,300
Nancy Ratner, PHD Mitogenic Activities in Neurofibromatosis National Institutes of Health R01 NS028840 9/15/2011 - 7/31/2017 $353,813
Nancy Ratner, PHD Disordered Regulation of Wnt/B-catenin Signaling in MPNST Development and Maintenance National Institutes of Health (University of Minnesota) R01 NS086219 8/15/2014 - 6/30/2019 $274,835
Nancy Ratner, PHD Brain Dysfunction in Neurofibromatosis National Institutes of Health R01 NS091037 4/1/2015 - 3/31/2020 $309,792
Nancy Ratner, PHD Novel Combinatorial Therapies for Malignant Peripheral Nerve Sheath Tumors National Institutes of Health R21 NS084885 7/1/2014 - 6/30/2016 $379,455
Nancy Ratner, PHD Ras Proteins in Nerve Tumorigenesis National Institutes of Health R37 NS083580 4/1/2014 - 3/31/2019 $390,000
Damien Reynaud, PHD Systemic Metabolic Disorders and Leukemic Clonal Dominance Conquer Cancer Foundation Reynaud, Damien, CCF 7/1/2014 - 6/30/2016 $60,000
Damien Reynaud, PHD Investigating the Mechanisms of Leukemia Initiation in the Context of Obesity Department of Defense Army W81XWH1510344 9/1/2015 - 8/31/2018 $187,200
Navneet Kumar Singh, PHD Modeling and Targeting of Oncogenic Liability in Drug-Resistant Breast Cancer Department of Defense Army W81XWH1610028 3/1/2016 - 2/28/2019 $186,272
Mitchell Springer, PHD Training Program in Cancer Therapeutics National Institutes of Health (University of Cincinnati) T32 CA11786 8/1/2013 - 7/31/2016 $45,432
Daniel T. Starczynowski, PHD Investigating Genetic and Molecular Determinants of Myelodysplastic Syndromes The Leukemia and Lymphoma Society 133416 7/1/2015 - 6/30/2020 $110,001
Daniel T. Starczynowski, PHD Defining the Role and Therapeutic Potential of TNF Recep Receptor-Associated Factor 6 in Myelodysplastic Syndromes Gabrielle's Angel Fnd for Cancer Research GAFCR 6/1/2013 - 5/31/2017 $75,000
Daniel T. Starczynowski, PHD Molecular Pathogenesis of MDS National Institutes of Health R01 DK102759 8/15/2014 - 5/31/2017 $233,135
Daniel T. Starczynowski, PHD Identification and Characterization of Genes in del(5q) Myelodysplastic Syndrome National Institutes of Health R01 HL111103 12/1/2015 - 11/30/2016 $382,500
Daniel T. Starczynowski, PHD Role of TRAF6 in Myelodysplastic Syndromes National Institutes of Health R01 HL114582 8/1/2014 - 4/30/2018 $398,308
Daniel T. Starczynowski, PHD Chronic Innate Immune Signaling in the Pathogenesis of MDS Edward P. Evans Foundation Starczynowski, Dan, 7/1/2014 - 6/30/2017 $200,000
Ronald R Waclaw, PHD Signaling Pathways Regulating Oligodendrocyte Development and Function National Institutes of Health R01 NS088529 4/1/2015 - 2/29/2020 $427,986
Jianqiang Wu, MD Exploring the Plexiform Neurofibroma Interactome Johns Hopkins School of Medicine (Neurofibromatosis Therapeutic) JHU 5/15/2013 - 11/14/2015 $80,550
Lai Man Wu, PHD Functional Study of Transcriptional Regulator Sip1 in Myelination and Remyelination National Multiple Sclerosis Society FG2045A1T 10/1/2013 - 9/30/2016 $56,657
Mei Xin, PHD Hippo Signaling in Heart Development and Repair National Institutes of Health R01 HL132211 4/1/2016 - 3/31/2021 $390,000
Yi Zheng, PHD Cincinnati Center for Excellence in Molecular Hematology National Institutes of Health P30 DK090971 9/30/2010 - 9/30/2016 $293,603
Yi Zheng, PHD Targeting Cdc42 for Bone Marrow Transplant Therapies National Institutes of Health R01 CA193350 5/1/2015 - 4/30/2020 $356,850
Yi Zheng, PHD Cdc42, Hematopoietic Stem Cell Polarity and Cell Fate National Institutes of Health R01 DK104814 12/15/2015 - 11/30/2019 $496,716
Yi Zheng, PHD
Hartmut Geiger, PHD		 Stem Cell Aging and Biomarker Studies National Institutes of Health R56 AG050650 9/15/2015 - 8/31/2016 $390,000
Yi Zheng, PHD Novel Sensitizers for Proton Therapy in Childhood Lymphoma Hyundai Hope on Wheels Zheng, Yi, HHOW 9/1/2015 - 8/31/2016 $50,000
Total Annual Grant Award Dollars $13,265,497

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Matthew Flick, PHD Novo Nordisk Pharmaceuticals $82,277
Dao Pan, PHD Shire International GmbH $1,355,955
Total Annual Industry Award Dollars $1,438,232